NL-OMON53301尚未招募不适用
Increasing the CTC detection sensitivity through FETCH technology - FETCH-CTC
niversiteit Twente0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Diagnosed metastatic breast cancer OR metastatic castration resistant prostate
- •A planned blood collection
- •At least 18 years of age
排除标准
- •No informed consent
研究者
相似试验
尚未招募
4 期
Improvement of detection of clinically significant prostate cancer by combination of molecular urine markers and multiparametric MRI of the prostateC61Malignant neoplasm of prostateDRKS00019892Klinik für Urologie Uniklinik Köln640
尚未招募
不适用
Experimental CFTR correctors for the treatment of Cystic fibrosis.Cystic FibrosisNL-OMON46144Erasmus MC Rotterdam2
招募中
不适用
A new finding on CT, K-sign, to detect the early-stage pancreatic cancerPancreatic cancerJPRN-UMIN000042498Tokyo Dental College Ichikawa General Hospital50
尚未招募
不适用
Reappraise of sensitivity and specificity detecting fatty liver using ultrasonography with MRI proton density fat fraction as the reference standardDiseases of the digestive systemKCT0002266Hanyang University Seoul Hospital184
尚未招募
不适用
Validation of circulating tumor cells (CTC) detection techniques in patients with advanced solid tumorsAdvanced cancer10027655NL-OMON33920Antoni van Leeuwenhoek Ziekenhuis200